主要文件

查看所有文档

C117307

溴代环丙烷

Name: 溴代环丙烷
Brand: ALDRICH

99%

别名:

环丙基溴

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₃H₅Br

化学文摘社编号:

4333-56-6

分子量:

120.98

UNSPSC Code:

12352100

NACRES:

NA.22

PubChem Substance ID:

24892372

EC Number:

224-375-7

Beilstein/REAXYS Number:

1900287

MDL number:

MFCD00001271

Assay:

99%

Form:

liquid

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

200

assay

99%

form

liquid

refractive index

n20/D 1.458 (lit.)

bp

69 °C (lit.)

density

1.51 g/mL at 25 °C (lit.)

storage temp.

2-8°C

SMILES string

BrC1CC1

InChI

1S/C3H5Br/c4-3-1-2-3/h3H,1-2H2

InChI key

LKXYJYDRLBPHRS-UHFFFAOYSA-N

说明

General description

溴环丙烷是有机合成的关键中间体，也是药物开发中构建多种化学结构的基础材料。

pictograms

GHS02

signalword

Danger

hcodes

H225

pcodes

P210 - P233 - P240 - P241 - P242 - P243

Hazard Classifications

Flam. Liq. 2

存储类别

3 - Flammable liquids

wgk

WGK 3

flash_point_f

21.2 °F - closed cup

flash_point_c

-6 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

法规信息

危险化学品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Lysosomal membrane permeabilization is an early event in Sigma-2 receptor ligand mediated cell death in pancreatic cancer.

John R Hornick et al.

Journal of experimental & clinical cancer research : CR, 31, 41-41 (2012-05-04)

Sigma-2 receptor ligands have been studied for treatment of pancreatic cancer because they are preferentially internalized by proliferating cells and induce apoptosis. This mechanism of apoptosis is poorly understood, with varying reports of caspase-3 dependence. We evaluated multiple sigma-2 receptor

1-Cyclohexyl-4-(4-arylcyclohexyl)piperazines: Mixed σ and human Δ(8)-Δ(7) sterol isomerase ligands with antiproliferative and P-glycoprotein inhibitory activity.

Carmen Abate et al.

ChemMedChem, 6(1), 73-80 (2010-11-12)

Many new chemotherapeutic agents are under preclinical investigation and, despite efforts to more selectively target cancer cells, limitations such as toxicity and inherent resistance are often encountered. Therefore, alternative strategies are needed to treat cancer and overcome such limitations. We

Novel derivatives of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with improved fluorescent and σ receptors binding properties.